73.88
Overview
News
Price History
Option Chain
Financials
Why MET Down?
Discussions
Forecast
Dividend History
Metlife Inc stock is traded at $73.88, with a volume of 2.34M.
It is down -1.03% in the last 24 hours and up +4.65% over the past month.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
See More
Previous Close:
$74.65
Open:
$74.61
24h Volume:
2.34M
Relative Volume:
0.59
Market Cap:
$48.17B
Revenue:
$77.08B
Net Income/Loss:
$3.40B
P/E Ratio:
15.68
EPS:
4.711
Net Cash Flow:
$18.11B
1W Performance:
+4.47%
1M Performance:
+4.65%
6M Performance:
-7.38%
1Y Performance:
+3.90%
Metlife Inc Stock (MET) Company Profile
Name
Metlife Inc
Sector
Industry
Phone
212-578-5500
Address
200 PARK AVENUE, NEW YORK, NY
Compare MET vs MFC, AFL, PUK, PRU
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MET
Metlife Inc
|
73.88 | 48.68B | 77.08B | 3.40B | 18.11B | 4.711 |
|
MFC
Manulife Financial Corp
|
36.52 | 61.33B | 43.74B | 4.21B | 23.02B | 2.2184 |
|
AFL
Aflac Inc
|
110.70 | 58.25B | 17.16B | 3.65B | 2.56B | 6.8855 |
|
PUK
Prudential Plc Adr
|
30.30 | 38.29B | 27.81B | 4.12B | 1.87B | 3.07 |
|
PRU
Prudential Financial Inc
|
96.90 | 33.77B | 60.77B | 3.73B | 6.27B | 10.00 |
Metlife Inc Stock (MET) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-16-25 | Initiated | Mizuho | Outperform |
| Sep-19-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-16-25 | Initiated | Wolfe Research | Outperform |
| Jan-23-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-09-24 | Initiated | TD Cowen | Buy |
| Sep-05-24 | Initiated | Barclays | Overweight |
| Jan-08-24 | Upgrade | Goldman | Neutral → Buy |
| Nov-17-23 | Resumed | Barclays | Overweight |
| Oct-05-23 | Initiated | Deutsche Bank | Hold |
| Sep-14-23 | Upgrade | Jefferies | Hold → Buy |
| Jan-09-23 | Downgrade | Goldman | Buy → Neutral |
| Dec-09-22 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-22 | Initiated | Raymond James | Mkt Perform |
| Jun-23-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-24-22 | Initiated | Citigroup | Buy |
| Jan-26-22 | Initiated | Jefferies | Buy |
| Jan-21-22 | Initiated | Wolfe Research | Peer Perform |
| Jan-12-22 | Reiterated | UBS | Buy |
| Jan-05-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-03-21 | Initiated | Goldman | Buy |
| Apr-21-21 | Initiated | UBS | Buy |
| Jan-06-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Upgrade | Citigroup | Neutral → Buy |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-17-20 | Initiated | Barclays | Overweight |
| Jun-01-20 | Resumed | BofA/Merrill | Buy |
| Mar-16-20 | Upgrade | Citigroup | Sell → Neutral |
| Jan-07-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-16-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-19-19 | Downgrade | Sandler O'Neill | Buy → Hold |
| Jan-16-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jan-02-19 | Upgrade | Sandler O'Neill | Hold → Buy |
| Jun-04-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-25-18 | Initiated | Credit Suisse | Outperform |
| Mar-26-18 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Jan-02-18 | Initiated | Deutsche Bank | Hold |
| Nov-10-17 | Downgrade | Sandler O'Neill | Buy → Hold |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| May-25-17 | Upgrade | FBR & Co. | Mkt Perform → Outperform |
| Mar-06-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jan-26-17 | Initiated | Citigroup | Sell |
| Dec-09-16 | Downgrade | Standpoint Research | Buy → Hold |
View All
Metlife Inc Stock (MET) Latest News
Cantor Fitzgerald Investment Advisors L.P. Sells 30,901 Shares of MetLife, Inc. $MET - MarketBeat
MetLife (NYSE:MET) Stock Rating Upgraded by Wall Street Zen - MarketBeat
MetLife Inc. stock outperforms competitors despite losses on the day - MarketWatch
Today's Analyst Rating Data for MetLife (MET) | MET Stock News - GuruFocus
Wells Fargo & Company Has Lowered Expectations for MetLife (NYSE:MET) Stock Price - MarketBeat
MetLife Inc stock: UBS Buy rating and $102 target signal upside potential - AD HOC NEWS
Trilogy Capital Inc. Makes New Investment in MetLife, Inc. $MET - MarketBeat
Evercore ISI Group Raises Target Price for MetLife (MET) to $96. - GuruFocus
MetLife Investment Management Originates $26 Billion in Private Fixed Income Deals - National Today
MetLife (MET) Boosts Private Fixed Income Portfolio - GuruFocus
UBS Adjusts Price Target on MetLife to $102 From $98, Maintains Buy Rating - marketscreener.com
MetLife unit MIM reported $26B in fixed income deals; AUM hit $144.7B - MSN
MetLife (MET) Expands AUM with $26B in Private Fixed Income Deals - GuruFocus
Wells Fargo Adjusts Price Target on MetLife to $90 From $93, Maintains Overweight Rating - marketscreener.com
MetLife Investment Management Originates $26 Billion in Private Fixed Income Transactions in 2025 - The Joplin Globe
MetLife’s investment arm made $26B in 2025 private deals, led by housing - Stock Titan
What to Expect From MetLife's Q1 2026 Earnings Report - Barchart.com
Jefferies Adjusts Price Target on MetLife to $92 From $96, Maintains Buy Rating - marketscreener.com
BMO Capital Adjusts Price Target on MetLife to $78 From $80, Maintains Market Perform Rating - marketscreener.com
Evercore ISI Adjusts Price Target on MetLife to $96 From $95, Maintains In Line Rating - marketscreener.com
MetLife Foundation Awards Grants to 26 Non-Profits in Asia As Part of Global Program Addressing Essential Community Needs - Business Wire
MetLife (MET.PF) Stock Trends and Sentiment 2026 - MarketBeat
MetLife Inc. stock outperforms competitors on strong trading day - MarketWatch
MetLife to Announce First Quarter 2026 Results - Bluefield Daily Telegraph
MetLife Inc (MET) Stock Price Up 3.38% on Apr 8 - GuruFocus
MET: Barclays Adjusts Price Target but Maintains Overweight Rati - GuruFocus
Barclays Cuts MetLife (NYSE:MET) Price Target to $89.00 - MarketBeat
Fundamentals Check: Is MetLife Inc stock good for income investorsCPI Data & Step-by-Step Swing Trade Plans - baoquankhu1.vn
MetLife Foundation Awards Over $6.5 Million Globally to Address Essential Community Needs - Business Wire
Why Is MetLife, Inc. (MET) Stock Down Today? - Meyka
MetLife, Inc. $MET Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat
MetLife Investment Management Hires New Head of Real Estate, Agriculture From Blackstone - ai-cio.com
Guardian Equity Income VIP Fund's MetLife Inc(MET) Holding History - GuruFocus
How Metlife Inc. (MET) Affects Rotational Strategy Timing - Stock Traders Daily
Sit Dividend Growth Fund's MetLife Inc(MET) Holding History - GuruFocus
Latest MET NewsMetLife to Hold Conference Call for Third Qu... - Stock Titan
Why workers stay put: MetLife says cost stress is driving job hugging - Stock Titan
Barclays Adjusts MetLife Price Target to $89 From $92, Maintains Overweight Rating - marketscreener.com
MetLife (MET) Releases Preliminary Variable Investment Income fo - GuruFocus
MetLife, Inc. 8-K SEC Filing Summary April 7, 2026 – Company Information, Stock Listings, and Regulatory Details - Minichart
Who's Moving Where In Wealth Management? – Aiviq, MetLife - Family Wealth Report
MetLife reports preliminary Q1 variable investment income of $475-$525 million By Investing.com - Investing.com
MetLife Issues Preliminary First-Quarter Variable Investment Income - TipRanks
MetLife Inc estimates Q1 2026 variable investment income of $475 million-$525 million pre-taxSEC filing - marketscreener.com
Metlife IncEstimates Q1 2026 Variable Investment Income Of $475 Million-$525 Million Pre-TaxSEC Filing - TradingView
MetLife (NYSE: MET) outlines Q1 2026 variable investment income outlook - Stock Titan
MetLife Investment Management appoints Andrea Drasites to lead real estate and agricultural finance - Prop News Time
MetLife (NYSE: MET) misses Q4 CY2025 revenue estimates - MSN
Morgan Stanley Lowers Price Target on MetLife to $89 From $93, Keeps Overweight Rating - marketscreener.com
MetLife, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Market Metrics - Markets Mojo
MetLife Prices Remarketing of Series C Senior Component Debentures - Yahoo
Metlife Inc Stock (MET) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):